Literature DB >> 6982286

Failure of host axons to regenerate through a once successful but later rejected long nerve allograft.

A A Zalewski, W K Silvers, A K Gulati.   

Abstract

Host axons will regenerate through a long nerve allograft in an immunologically tolerant rat. However, if tolerance is abolished, rejection occurs and allogeneic cells (e.g., Schwann, vascular, perineurial, etc.) as well as regenerated host axons disappear from the allograft. Because following tolerance abolition host axons begin to regenerate into the connective tissue remnants of the rejected nerve allografts, the extent of this renewed axonal growth was investigated. It was found that in a tolerance-abolished rat, host axons only regrew in to the proximal 1 cm of a 4-cm allograft which in a fully tolerant recipient would have had numerous allogeneic Schwann cell-myelinated axons throughout its length. It is concluded that viable allogenic cells (i.e., Schwann, fibroblast, and vascular) together with their connective tissue matrix provide the best way to aid host nerve fiber regeneration through a long nerve allograft.

Entities:  

Mesh:

Year:  1982        PMID: 6982286     DOI: 10.1002/cne.902090404

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  3 in total

1.  Role of timing in assessment of nerve regeneration.

Authors:  Michael J Brenner; Arash Moradzadeh; Terence M Myckatyn; Thomas H H Tung; Allen B Mendez; Daniel A Hunter; Susan E Mackinnon
Journal:  Microsurgery       Date:  2008       Impact factor: 2.425

2.  Immunogenicity and regenerative potential of acellular nerve allografts to repair peripheral nerve in rats and rabbits.

Authors:  A K Gulati; G P Cole
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 3.  Reconstruction of Critical Nerve Defects Using Allogenic Nerve Tissue: A Review of Current Approaches.

Authors:  Tim Kornfeld; Anton Borger; Christine Radtke
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.